Fortress Biotech FBIO Institutional Ownership

Updated Oct 10, 2026

Fortress Biotech, Inc. (NASDAQ:FBIO) had 56 institutional holders reporting a position on Form 13F for the quarter ended June 30, 2026.

• Together they owned 17.53% of the outstanding stock in Q2 2026, up from 16.15% a quarter earlier.
• Total shares held in FBIO rose 8.94% from Q1 2026; the number of holders rose 19.15% from Q2 2025.
• Of the 56 holders, 27 added to their positions, 18 reduced their stakes and 11 left their positions unchanged in Q2 2026.
• Combined, institutional investors held 5.84Mn shares of FBIO as of Q2 2026, up 478.96K from the prior quarter and up 1Mn from a year earlier.
• Vanguard Capital Management LLC held the largest position in FBIO at 1.04Mn shares as of June 30, 2026, or 3.11% of shares outstanding.
• The biggest increases in FBIO positions during Q2 2026 came from GSA Capital Partners LLP (+204.34K shares), Vanguard Capital Management LLC (+71.17K shares), Acadian Asset Management LLC (+66.85K shares), Integrated Wealth Concepts LLC (+45.2K shares) and UBS Group AG (+37.87K shares).
• The biggest cuts to FBIO positions during Q2 2026 came from Northern Trust Corp (-166.42K shares), Susquehanna International Group, LLP (-163.74K shares), Opaleye Management Inc. (-152K shares), Citadel Advisors LLC (-103.22K shares) and Simplex Trading, LLC (-43.82K shares).
• Per Business Quant data, the 10 largest holders of Fortress Biotech at the end of Q2 2026 were Vanguard Capital Management LLC (1.04Mn shares), Opaleye Management Inc. (890K shares), Mackenzie Financial Corp (555.68K shares), GSA Capital Partners LLP (458.47K shares), Shikiar Asset Management Inc (305.47K shares), Geode Capital Management, LLC (300.52K shares), BlackRock, Inc. (224.78K shares), Two Sigma Investments, LP (213.79K shares), Bridgeway Capital Management, LLC (177.37K shares) and Vanguard Fiduciary Trust Co (166.37K shares).